Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

ANG Lifesciences India Ltd - 540694 - Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015

 ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 ('LODR'), we hereby inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Monday, September 5th, 2022 at 4:00 PM at the Registered Office of the Company, inter-alia, to transact the agendas as mentioned herewith notice of board meeting
29-08-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Reg 30 & 47 of SEBI LODR, 2015, please find enclosed herewith copies of newspaper advertisment of unaudited consolidated and standalone financial result for quarter ended as at 30th June 2022.
17-08-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclosed the Investor Presentation of ANG Lifesciences India Limited.
14-08-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Outcome Of Board Meeting Pursuant To Reg. 30 Of SEBI (Listing Obligation And Disclosure Requirements), Regulation, 2015.

 Pursuant to Regulation 30 & 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board of Directors in its meeting held on 14th August, 2022 has considered and approved the Un-Audited Consolidated & Standalone Financial Results of the Company for the quarter ended 30th June, 2022 along with the limited review report thereon issued by M/s Raman Wadhwa & Co., Statutory Auditors of the Company.
14-08-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015

 ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 ('LODR'), we hereby inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on August 14", 2022 at 4:00 PM at the Registered Office of the Company, inter-alia, to transact the following business:- 1.To consider and approve the Standalone Unaudited Financial Results along with Limited review report thereon for the quarter ended on 30" June, 2022. 2. Transact any other matter, if any with permission Please take the same on your record.
05-08-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Statement Of Investor Complaints For The Quarter Ended June 2022

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Renu KaurDesignation :- Company Secretary and Compliance Officer
18-07-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Meeting Updates

 Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, this is to inform you that Board of Directors of the Company on 15th July, 2022 has allotted 25,91,657 Equity Shares having face value of Rs.10 each as Fully-Paid up Bonus shares in the ratio of 1:4 i.e. 1 (One) new fully paid-up equity shares each for every 4 (Four) existing fully paid -up equity shares of Rs. 10 each to all the eligible members of the Company, whose name appear in the Register of members/list of beneficiary owners as on 14.07.2022 (being the record date fixed for this purpose).
15-07-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Dear Sir/ Madam, With reference to the captioned subject, we hereby submit the confirmation Certificate received from M/s. Bigshare Services Private Limited, Registrar and Share Transfer Agent (RTA) as per Regulation 74(5) of the Securities and Exchange Board India (Depository and Participant) Regulations, 2018 for the Quarter ended on 30th June, 2022. Kindly acknowledge the information and take the same on your record.
11-07-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Intimation Of In-Principle Approval For Issue & Proposed Allotment Of Bonus Equity Shares

 The Company has received the In-principle approval from BSE dated 08th July 2022 in regards to issue and proposed allotment of bonus equity shares in the ratio of 1:4
09-07-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 ANG Lifesciences India Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
05-07-2022
Next Page
Close

Let's Open Free Demat Account